(Reuters Health) – People with obesity who undergo bariatric surgery have a higher risk of gastroesophageal reflux disease (GERD) with sleeve gastrectomy than with Roux-en-Y gastric bypass, a randomized controlled trial found. Researchers randomized patients with severe obesity and type 2 diabetes to undergo either sleeve gastrectomy (n=55) or Roux-en-Y gastric bypass (n=54). At baseline,
Patients with obesity who had bariatric surgery had a lower risk of having a major adverse cardiovascular event (MACE) or dying from all causes during a median 7-year follow-up, compared with similar patients who did not undergo surgery. These findings, from a province-wide retrospective cohort study from Quebec, follow two recent, slightly shorter similar trials.
Dr Maria S. Altieri There is a need to update the current criteria for the bariatric/metabolic surgery indication to include patients with a body mass index (BMI) of 30 to 35 kg/m2 (class 1 obesity), says the lead author of a new study. The research showed that “bariatric surgery is effective in weight loss and